Patents/Inventors

Paul Parren

OdijkNL31 patents

24 Patents

US126178542026
Humanized or Chimeric CD3 Antibodies
GENMAB A/S
0 cites
US125953162026
Bispecific and Multispecific Antibodies and Method for Isolation of Such
GENMAB A/S
0 cites
US125891502026
Antibodies Binding AXL
GENMAB A/S
0 cites
US125773162026
Methods of Use of Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies
GENMAB HOLDING B.V.
0 cites
US125707512026
Binding Agents Binding to PD-L1 and CD137 and Use Thereof
BIONTECH SE
0 cites
US124484592025
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies and Methods of Use Thereof
GENMAB HOLDING B.V.
0 cites
US124213192025
Binding Agents That Bind OX40 (CD134) and Method of Use Thereof to Treat Disease
GENMAB A/S
0 cites
US123311232025
Agent, Uses and Methods for Treatment
H. Lundbeck A/S
0 cites
US122757972025
Anti-cd37 Antibodies and Anti-cd20 Antibodies, Compositions and Methods of Use Thereof
GENMAB HOLDING B.V.
0 cites
US122470772025
Bispecific Egfr/c-met Antibodies
Janssen Biotech, Inc.
0 cites
US122470802025
Anti-dr5 Antibodies and Methods of Use Thereof
GENMAB B.V.
0 cites
US122470652025
Method for Producing a Controlled Mixture of Two or More Different Antibodies
GENMAB A/S
0 cites
US121730762024
Polypeptide Variants and Uses Thereof
GENMAB B.V.
0 cites
US120775962024
Multispecific Antibodies Against CD40 and CD137
Biontech SE
0 cites
US120495122024
Antibody Variants and Uses Thereof
GENMAB B.V.
0 cites
US119705442024
Antibodies
GENMAB A/S
0 cites
US119393882024
Multispecific Antibodies Against CD40 and CD137
Biontech SE
0 cites
US118665142024
Heterodimeric Antibody Fc-containing Proteins and Methods for Production Thereof
GENMAB A/S
0 cites
US118144112023
Nucleic Acid Molecules Encoding Binding Agents to CD40 and 4-1BB (CD137)
GENMAB A/S
0 cites
US117952142023
Modulation of Complement-dependent Cytotoxicity Through Modifications of the C-terminus of Antibody Heavy Chains
GENMAB A/S
0 cites
US116135752023
Humanized or Chimeric CD3 Antibodies
GENMAB A/S
0 cites
US115781412023
Bispecific Antibodies Against HER2 and CD3
GENMAB A/S
0 cites
US115489502023
Agent, Uses and Methods for Treatment
H. Lundbeck A/S
0 cites
US115423232023
Agents, Uses and Methods for the Treatment of Synucleinopathy
H. Lundbeck A/S
0 cites